Clinical trial

Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects

NCT02820155

Study summary

ClinicalTrials.gov

Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention RGN1016 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE1

Conditions

Healthyunresolved

Interventions

RGN1016DRUG

PlaceboDRUG

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

National Taiwan Universitycollaborator

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02820155 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.